Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000229·Replimune Group, Inc.
Schedule 13G ownership disclosure
Replimune Group Inc
Common Stock · CUSIP: 76029N106
Event date: 2024-12-31
- Filing-level shares
- 3,595,848
- Percent of class
- 4.77%
- The Vanguard Group
Shares: 3,595,848 · Class: 4.77%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000229
- Form type
- SCHEDULE 13G/A
- Filer
- Replimune Group, Inc.
- CIK
- CIK 1737953
- Filed
- Jan 31, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership